Boryung wins patent nullification trial over oxaliplatin
The company announced on June 4 that it secured the right to sell a generic version of Sanofi-Aventis’s Eloxatin on the Korean market after the Patent Court of Korea said that Eloxatin lacks any novelty in its paten...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
